bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.730
-0.150 (-7.98%)
At close: Jun 5, 2026, 4:00 PM EDT
1.770
+0.040 (2.31%)
After-hours: Jun 5, 2026, 7:56 PM EDT
bioAffinity Technologies Employees
bioAffinity Technologies had 57 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
57
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$99,296
Profits / Employee
-$278,596
Market Cap
7.84M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 57 | 0 | - |
| Dec 31, 2024 | 57 | -18 | -24.00% |
| Dec 31, 2023 | 75 | 61 | 435.71% |
| Dec 31, 2022 | 14 | 3 | 27.27% |
| Dec 31, 2021 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Inotiv | 2,046 |
| Burning Rock Biotech | 667 |
| MDxHealth | 364 |
| XWELL | 280 |
| Exagen | 220 |
| Precipio | 71 |
| Advanced Biomed | 31 |
| Quantum Cyber | 13 |
BIAF News
- 3 days ago - BioAffinity Technologies announces SAB to host webinar on CyPath Lung - TheFly
- 3 days ago - Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies' Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar - Business Wire
- 9 days ago - BioAffinity Technologies announces notification of Mexico patent allowance - TheFly
- 9 days ago - bioAffinity Technologies Announces Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using CyPath® Lung Technology - Business Wire
- 24 days ago - BioAffinity says CyPath Lung test unit sales achieved monthly record in April - TheFly
- 24 days ago - bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026 - Business Wire
- 4 weeks ago - BioAffinity Technologies reports Q1 EPS (81c) vs. ($4.80) last year - TheFly
- 4 weeks ago - bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung - Business Wire